OHSU coronavirus (COVID-19) response
As of Friday, Jan. 15
OHSU staff vaccinations
As of 8 a.m., Jan. 15, OHSU has received 34,575 Pfizer and Moderna doses and administered 19,493 vaccines to employees and learners (15,880 first doses and 3,613 second doses). Last weekend, OHSU administered 2,194 vaccines to SEIU 503 and independent home health care workers, first responders and home health care workers. Adventist loaned OHSU 1,000 Moderna doses for use at the SEIU 503 clinics, which we will return Jan. 19.
Patients hospitalized with COVID-19
- OHSU: 14
- Hillsboro Medical Center: 8
- Adventist Health Portland: 17
Additional OHSU-specific data
- Since Feb. 28, 2020, there have been 116,741 patients tested. Among those, a total of 10,595 COVID-19 cases have been detected; 14 patients are currently in hospital; and, 347 patients have tests pending. There have been 40 in-hospital deaths.
- There have been 56 new detected patient cases since Jan. 14.
- To date, OHSU has completed 20,192 COVID-19 tests for 7,857 staff and students. Of those, 452 tests for 438 staff and students detected COVID-19; 19,625 tests for 7,610 individuals resulted in not detected; 115 tests are pending.
As the state's academic health center, Oregon Health & Science University remains engaged with state and local public health authorities and health systems across the metro area to coordinate a regional response to the COVID-19 pandemic. The goal is to contain the spread of the virus, including through the use of vaccines that first arrived at OHSU on Dec. 15.
Beginning in the earliest days of the pandemic, OHSU activated an emergency operations center that adapted response plans already in place from previous pandemic influenza outbreaks.
OHSU has prepared to treat a surge of patients with COVID-19, while working proactively to contain the spread of the SARS-CoV-2 virus and protect our workforce.
Mobile, drive-through testing sites
As Oregon’s academic health center, OHSU is committed to ensuring all Oregonians have access to COVID-19 testing and appropriate health care, particularly people of color and other individuals from communities hardest hit by COVID-19.
To achieve this goal, OHSU has established two low-barrier drive-up testing facilities in the Portland region at the Oregon Convention Center and Hillsboro Stadium. These low-barrier facilities do not require an appointment or referral, are free to the patient (although insurance will be charged if the patient has insurance) and are available to OHSU and non-OHSU patients alike. Low-barrier testing sites are extremely effective at providing access to testing for anyone who needs it. They are also extremely resource intensive.
OHSU’s COVID-19 mobile testing sites are currently providing tests to asymptomatic and symptomatic individuals, without appointment or referral, who meet criteria outlined in the Oregon Health Authority’s Guidance for clinicians regarding COVID-19 testing. (OHSU’s testing criteria are expected to change in accordance with Centers for Disease Control and OHA guidelines, and the availability of testing supplies.)
OHSU’s Hillsboro and Northeast Portland mobile sites together are testing more than 700 individuals per day, running two lanes at each site. Of those, between 10% and 20% are OHSU patients who require testing prior to receiving procedures or surgeries that are medically necessary. Advance testing helps ensure the health and safety of the care team and conserves scarce resources by ruling out the need for a higher level of personal protective equipment. The remaining 80% to 90% are individuals independently seeking testing, including those who have established care with other health systems.
Because OHSU offers few barriers to testing at our mobile testing sites and the region is seeing a record-breaking number of COVID-19 cases, we have seen a significant increase in individuals seeking testing. Unfortunately, the increased demand sometimes reults in long wait times – frequently up to four hours. These are the longest waits we have seen and are comparable to the spike in individuals seeking testing in late July.
To alleviate the bottleneck and increase access for high-risk groups, we have moved some of OHSU’s pre-surgical patient testing to at an outpatient clinic at the South Waterfront. On Dec. 7, OHSU dedicated the first two hours of daily operation for priority groups during periods of exceptionally high demand.
We have also reached out to Multnomah County and the state to discuss the need to increase the establishment of additional low-barrier testing sites in the Portland region in order to meet the significantly increased demand.
OHSU Health is offering coronavirus tests at the two following locations:
- Hillsboro Stadium – 4450 NE Century Blvd, Hillsboro, OR 97124
- Hours (note that wait times may vary depending on demand, and sites may close early):
- Monday - Thursday: 9 a.m. - 4 p.m.
- Friday: 7:30 a.m. - 2:30 p.m.
- Oregon Convention Center – 777 NE Martin Luther King Jr. Blvd., Portland, OR 97232 (enter on Lloyd Boulevard into parking garage A). Note that flu shots are also being offered at this site.
- Hours (note that wait times may vary depending on demand, and sites may close early):
- Monday through Friday: 8 a.m. to 8 p.m.
Who can get tested?
Note: If you are a Kaiser, Legacy or Providence patient, you will be directed to those health care systems.
- Those with symptoms: People over age 2 months can be tested if they have one or more of the following:
- Shortness of breath
- Trouble breathing
- Or at least two of the following symptoms:
- Repeated shaking with chills
- Muscle pain
- Sore throat
- New loss of taste or smell
- Nausea / vomiting
- Those without symptoms: People without symptoms can get tested if they meet any of the following:
- They are giving birth, or they are having surgery or another qualifying procedure at OHSU.
- They have a vulnerable immune system and are following steps to end isolation (tested positive at least 14 days ago AND have not had any symptoms for 14 days).
- They have been in close contact with someone who has been diagnosed with COVID-19.
- A public health department has required them to get tested for contact tracing.
- One or more of the following:
- The person is a migrant/seasonal agricultural worker.
- The person is Black, African-American, Latinx, American Indian/Alaska Native, Asian, Asian-American or Pacific Islander.
- The person has a disability.
- English is not the person's first language.
- In addition:
- People without symptoms who test negative will not be able to get a repeat test for at least seven days.
- OHSU is no longer testing people who previously tested positive until 90 days after they were first diagnosed.
OHSU’s testing criteria follow Oregon Health Authority and CDC recommendations. Guidelines may change at any time based on updated recommendations.
- Patient visitation: Support of friends and family is an important part of healing. Details of OHSU’s current patient visitation policy can be found here.
- OHSU has implemented a “mask on” policy for all patients, visitors and staff inside the hospital. For employees, this means anyone working in a patient-care area, in hallways, and in research labs. All employees who work in patient care areas will receive masks provided by OHSU. OHSU is asking all employees to conserve supplies as much as safely possible to preserve these precious resources for the entire institution and their colleagues.
- OHSU’s research community came together to launch an in-house COVID-19 testing lab on March 24. The lab is an example of the many collaborations that have been happening at OHSU and in the health care community. In this case, members of the research community rallied to support the clinical community and testing in a drive to combat COVID-19. The lab's capacity greatly expanded in October.
- OHSU’s Telemedicine Program offers an opportunity for patients to consult with licensed clinicians through a telephone or video connection from their home, limiting barriers to health care access. The service has expanded exponentially in response to COVID-19.
- OHSU clinicians and scientists partnered with Oregon-based Nike to develop locally made personal protective equipment for health care workers treating patients with COVID-19.
- OHSU School of Medicine students jumped into the health care workforce three months early to immediately help address COVID-19 in Oregon.
- OHSU’s emergency preparedness group has adapted response plans in place from previous disease outbreaks.
- OHSU is closely coordinating with state and regional public health agencies, as well as area health systems, to ensure adequate supplies of personnel, hospital space and equipment.
- Patient access support specialists and health care unit coordinators are vigilantly conducting travel and symptom screening questions, and helping with appropriate triage and masking of symptomatic patients.
- On Thursday, April 23, OHSU announced salary reductions and other measures to address mounting financial challenges due to the COVID-19 pandemic.
- On Friday, March 13, OHSU President Danny Jacobs, M.D., M.P.H., FACS, announced a series of measures, including a workforce guarantee and hardship fund, designed to strengthen the resilience of a workforce critical to the health and well-being of Oregonians.
- OHSU suspended work-related travel beginning the week of March 9, with exceptions primarily related to clinicians providing patient care to sites around the Portland metro area and Oregon. The goal is to minimize quarantines of health care workers and help to slow the spread of the virus.
- Because OHSU’s mission carries our scientists, students and clinicians around the world, we are also supporting employees who have traveled to locations with confirmed COVID-19 cases through measures including telework, paid administrative leave and guiding them through quarantine procedures when necessary.
- OHSU has instituted a wellness program designed to support clinicians, employees and students during the COVID-19 pandemic.
- OHSU is promoting physical distancing within the university, including by requiring non-critical function employees to work from home and minimizing the number of people gathered for in-person meetings through video and teleconferencing alternatives. To that end, the university's research mission has been curtailed, with the exception of research specifically related to the diagnosis, treatment and prevention of COVID-19.
Research and development
- On Nov. 30, OHSU announced it is part of a Phase 3 clinical trial for a vaccine candidate developed by Oxford University and the pharmaceutical company AstraZeneca.
- OHSU scientists and physicians are engaged in a multipronged effort across the institution to improve scientific understanding of the novel coronavirus and bring the pandemic under control.
- An OHSU-led evidence review confirms CDC guidance suggesting people with mild or no symptoms may be infectious for no more than about 10 days. People who are severely ill from COVID-19 may be infectious for as long as 20 days.
- OHSU is partnering with the local nonprofit Self Enhancement Inc. on a study that combines wastewater monitoring with voluntary saliva-based testing of residents in four Portland neighborhoods. If succesful, the pilot project could be expanded to additional areas.
- An OHSU-led evidence review, published in June, finds that facial coverings appear to decrease the risk of spreading respiratory illnesses in community settings.
- OHSU data scientist Peter Graven, Ph.D., modeled the projected unchecked spread of the virus and began sharing those projections with state and local policymakers in mid-March. These projections helped inform Oregon’s “Stay Home, Save Lives” efforts to reduce the spread of the virus and ensure it hasn’t exceeded the capacity of health systems to treat a surge of patients who required hospitalization.
- OHSU is part of a nationwide clinical trial testing whether convalescent plasma is effective in treating COVID-19.
- OHSU data scientists are leading a nationwide collaboration of clinicians, informaticians and other biomedical researchers aims to turn data from hundreds of thousands of medical records from coronavirus patients into effective treatments and predictive analytical tools that could help lessen or end the global pandemic.
- OHSU trauma surgeon Albert Chi, M.D., M.S.E., is leading an effort to generate low-cost ventilators using 3D printing technology. These ventilators could be useful in hot spots around the country and the world experiencing an overwhelming surge of critically ill patients.
- OHSU has joined with other universities and academic medical centers across the country to ease licensing requirements to expedite promising new technologies to diagnose, treat and prevent COVID-19.
- OHSU researchers are actively engaged in exploring COVID-19, including a recent publication describing practical measures that can be implemented to keep health care personnel and non-infected patients safe.
- On Dec. 3, Gov. Kate Brown appointed Louis Picker, M.D., as one of two Oregon scientists to independently review the safety and efficacy of COVID-19 vaccines that receive emergency use authorization from the U.S. Food and Drug Administration. On Dec. 11, Brown appointed OHSU Chief Administrative Officer Connie Seeley as special advisor for vaccine implementation in Oregon.
- On Nov. 6, Renee Edwards, M.D., joined chief medical officers from other Portland metro area health systems calling on the public to redouble efforts to prevent the spread of the virus through proven measures such as wearing facial coverings in public, maintaining physical distancing, and using hand hygiene.
- OHSU established a Connected Care Center, available by phone to people throughout Oregon seeking insight about care of symptoms related to COVID-19. The phone number is 833-647-8222.
- A longtime health outreach program, operated through OHSU Hillsboro Medical Center, is reaching directly into vulnerable communities to prevent the spread of the novel coronavirus among vineyard and winery workers across the Willamette Valley.
- Contact tracing has involved students in the OHSU School of Medicine and OHSU/Portland State University School of Public Health.
- OHSU is hosting a weekly video meeting that is drawing hundreds of primary care physicians across Oregon seeking reliable information about how to overcome the COVID-19 pandemic in every corner of the state.
- With respect to patients and visitors, anyone with respiratory symptoms who thinks they may have been exposed to someone with COVID-19 should first call their health care clinician before coming into a clinic, urgent care center or Emergency Department so that provisions can be made to minimize exposure of other patients.
- OHSU students have stepped up voluntary efforts to help people experiencing homelessness by sewing masks and delivering them to organizations serving the vulnerable and underserved.
- OHSU President Danny Jacobs, M.D., M.P.H., FACS, joined other national health care leaders in raising alarm about disparities in health outcomes along racial and socioeconomic lines among those stricken by COVID-19. OHSU researchers confirmed the disproportionate impact of the virus on Black and Hispanic populations with an evidence review published Dec. 1.
- The Oregon Poison Center at OHSU has ramped up its capacity to field inquiries around COVID-19, including knocking down myths circulating in social media.
Ways to help
- Donate to OHSU's COVID Emergency Response Fund: Financial donations will be used flexibly to address OHSU’s highest-priority needs in the coming weeks.
- Donate supplies: While OHSU currently has adequate supplies, we welcome generous community donations of specific items. If you would like to donate, please bring unopened and unused supplies to: Center for Health & Healing Building 1 Loading Dock, 3303 Bond Ave., Portland, OR 97239. Drop off donations between 9 a.m. and 5 p.m. Monday through Friday. Items needed are:
Please consult these resources for the most current information on the COVID-19 response: